, Tracking Stock Market Picks
Enter Symbol:
Cemex S.a.b. De C.v. (CX) [hlAlert]

In-line CX
down 22.00 %

Cemex S.a.b. De C.v. (CX) rated In-line with price target $7 by Imperial Capital

Posted on: Monday,  Aug 27, 2012  9:25 AM ET by Imperial Capital

Imperial Capital rated In-line Cemex S.a.b. De C.v. (NYSE: CX) on 08/27/2012. Previously Imperial Capital rated Underperform Cemex S.a.b. De C.v. (NYSE: CX)
on 06/28/2012., when the stock price was $5.99. Since then, Cemex S.a.b. De C.v. has gained 28.21% as of 10/23/2015's recent price of $7.68.
If you would have followed the previous Imperial Capital's recommendation on CX, you would have lost 22% of your investment in 1212 days.

CEMEX, S.A.B. de C.V. (CEMEX) is a Mexico-based holding company of entities whose main activities are oriented to the construction industry, through the production, marketing, distribution and sale of cement, ready-mix concrete, aggregates and other construction materials. CEMEX is a global cement manufacturer with operations in North America, Europe, South America, Central America, the Caribbean, Africa, the Middle East, Australia and Asia. The Company, through its operating subsidiaries, is engaged in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates and clinker. As of December 31, 2008, the Company?s main cement production facilities were located in Mexico, the United States, Spain, the United Kingdom, Germany, Poland, Croatia, Latvia, Colombia, Costa Rica, the Dominican Republic, Panama, Nicaragua, Puerto Rico, Egypt, the Philippines and Thailand. On December 26, 2008, the Company sold its Canary Islands operations.

Imperial Capital
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/27/2012 9:25 AM Sell
7.82 6.72
as of 12/31/2012
1 Week down  -1.54 %
1 Month down  -10.89 %
3 Months down  -18.48 %
1 YTD down  -21.10 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/28/2012 8:25 AM Sell
5.99 3.36

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy